Upper Extremity InjuryNCT05328934
SoftHand Comparison Study
A study testing SoftHand Pro and Ossur i-Limb in people with Upper Extremity Injury and Upper Extremity Deformities, Congenital, run by Mayo Clinic at 2 sites in United States.
Trial summary
A trial to compare the performance of the SoftHand Pro (SHP) and Ossur i-Limb in people with transradial limb loss over an 8-week period. Read more about this study
- Who is it for?
- Ages 18 to 99 years
- Conditions the study is for
- Upper Extremity Injury, Upper Extremity Deformities, Congenital, Amputation, Traumatic
- What is being tested?
- SoftHand Pro and Ossur i-Limb
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 36 participants
- Where
- 2 sitesUnited States
- Study dates
- 28 Apr 2022to 10 Apr 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 99 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- the individual can successfully use their prosthesis, list the components used and that their current prosthesis is fitting properly (by performing a tension analysis);
- the individual had unilateral transradial limb loss more than 6 months before the clinical evaluation because, to use a myoelectric prosthesis, the residual limb volume needs to be stable;
- the individual is a proficient owner of one or more common myoelectric prosthetic hands, such as the Sensor Hand Speed and Bebionic.
Who cannot join
- individuals who have had transradial amputation for less than 6 months;
- individuals who have been fit and trained to use a prosthesis but chose not to use one;
- individuals who use the i-Limb Quantum myoelectric prosthesis;
- symptomatic brachial plexopathy, cervical radiculopathy or polyneuropathy (observed);
- orthopedic, joint degeneration (i.e., arthritis, self-reported) affecting the hand or cervical spine that severely limit upper limb function (observed);
- visual problems that would interfere with the grasping;
Show all 10Show fewer
- co-existing central nervous system disease with symptoms that limit upper extremity function (e.g., multiple sclerosis, motor neuron disease, myasthenia gravis, Parkinson's disease, dystonia) revealed in medical history;
- limited range of motion as assessed through range of motion testing;
- inability to follow study instructions;
- use of medications that might affect sensory and/or motor functions.
Trial locations and contacts
2 sites in 1 country.
United States2 sites
Mayo Clinic
Rochester, Minnesota, 55905
Arizona State University
Tempe, Arizona, 85281-9709
About this study
Official title: Toward Use of the Synergy-based SoftHand Pro for Activities of Daily Living by Persons With Transradial Limb Loss: A Multi-site Clinical Trial
A trial to compare the performance of the SoftHand Pro (SHP) and Ossur i-Limb in people with transradial limb loss over an 8-week period.
Read the detailed description
This study will measure improvements in outcomes obtained from laboratory testing of the SHP and i-Limb from baseline to after 8 weeks of daily use. A secondary analysis will incorporate the subjects' existing prosthetic hands. Finally, surveys and usage data collected through the SHP and i-Limb firmware during daily use will complement data the aforementioned outcomes to explore factors that may be related to differences in grasping and manipulation performance.
- Conditions
- Upper Extremity Injury, Upper Extremity Deformities, Congenital, Amputation, Traumatic, Amputation, Congenital
- Being tested
- SoftHand Pro, Ossur i-Limb
- Medical subject headings
- Arm Injuries, Upper Extremity Deformities, Congenital, Amputation, Traumatic, Amputation, Congenital
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
SoftHand ProDevice
Performance assessments utilizing the SoftHand Pro over an 8-week period.
Ossur i-LimbDevice
Performance assessments utilizing the i-Limb over an 8-week period.
| Study group | Role | What they receive |
|---|---|---|
| Initial Assignment: SoftHand Pro | Experimental | This arm of the crossover design will begin the trial using the SoftHand Pro. Receives: Device: SoftHand Pro; Device: Ossur i-Limb |
| Initial Assignment: Ossur i-Limb | Active comparator | This arm of the crossover design will begin the trial using the i-Limb. Receives: Device: SoftHand Pro; Device: Ossur i-Limb |
What is being measured
The primary outcome is the main question the study is designed to answer.
Upper Extremity Functional Ability [1]
Change in upper extremity function, as measured by the Activities Measure for Upper Limb Amputees (AM-ULA). Participants complete 17 tasks, rated on task completion, speed of completion, movement quality, skillfulness of prosthesis use, and independence from the use of other assistive devices or adaptive environments with the prosthesis. The scale is 0 to 4, with a higher number representing higher performance in each category. Scores in each category are averaged for a Grade in each task. Grades for the 17 tasks are averaged and multiplied by 40 for a final score of 0 - 40, with a higher number representing higher overall function.
Measured: 8 Weeks
Secondary outcomes (9)
Upper Extremity Functional Ability [2]
Change in upper extremity function, as measured by the Action Research Arm Test (ARAT). Participants perform up to 19 tasks categorized by grasp, grip, pinch, and gross movement. The scale is 0 to 3, with a higher number representing higher performance in each category. Categories are scored separately.
Measured: 8 Weeks
Upper Extremity Manual Dexterity
Change in upper extremity gross manual dexterity, as measured by the Box and Blocks test. Participants are tested in a timed transfer of blocks from one side of a box to another side over a low partition. A higher number of blocks successfully transferred during the timed episode represents a higher level of upper extremity manual dexterity.
Measured: 8 Weeks
Hand Motor Function
Change in fine and gross motor hand function, as measured by the Jebsen-Taylor Hand Function Test. Participants are timed in seven activities of daily living closely involving use of the hand, with a lower number of seconds required to complete the task representing a higher level of motor hand function.
Measured: 8 Weeks
Occupational Performance
Change in participants' perceived occupational performance, as measured by the Canadian Occupational Performance Measure (COPM). Participants choose up to 5 occupational performance problems; their perception of their own performance and their satisfaction with their performance regarding each problem is measured on a 1 to 10 scale, with higher scores representing higher performance and satisfaction. The difference in performance and satisfaction is calculated, and then the differences for all problems together are totaled and averaged, with the average divided by the number of problems establishing the final score for each performance and satisfaction. Higher averages represent better perceived performance and satisfaction.
Measured: 8 Weeks
Quality of Life
Change in participants' perceived quality of life, as measured by the the World Health Organization Quality of Life Disabilities Module (WHOQOL-DIS). Participants answer qualitative questions regarding patient activities, independence, and overall quality of life on a 1 to 5 scale, with a higher number indicating a higher concurrence or frequency related to the item in question, and totaled for a score which categorizes patient quality of life.
Measured: 8 Weeks
Upper Extremity Function and Pain
Change in participants' perceived levels of upper extremity physical function and symptoms, as measured by the Disabilities of the Arm, Shoulder, and Hand Score (QuickDASH). Participants rate their difficulty with examples of physical function and their severity of physical symptoms on a 1 to 5 scale, with higher values representing more severe difficulties and symptoms. The scores are combined in a calculation which results in an overall score, with higher scores representing more severe overall difficulties and symptoms.
Measured: 8 Weeks
Overall Functional Performance
Change in participants' perceived functional performance, as measured by the Patient-Specific Functional Scale. Participants select 5 or more activities for which they perceive a problem, rating their own performance of that activity on a scale of 0 to 10, with higher values representing greater ability to perform the activity. The scores are totaled and divided by the number of tasks for an average score, with higher values representing better performance.
Measured: 8 Weeks
Prosthesis Overall Functional Utility
Change in participants' perception of the utility of their currently-used prosthesis, as measured by the Orthotics Prosthetics Users Survey - Upper Extremity Functional Status (OPUS). Participants rate the prosthetic's ease of use for a variety of daily activities, 23 of which are scored, on a 0 to 4 scale, with higher values representing easier use. Scores are totaled and converted to a 0 to 92 scale, with higher overall scores representing better functional utility with the prosthesis.
Measured: 8 Weeks
Arm Pain
Change in participants' levels of pain is measured for subjects who have pain due to brachial plexopathy or neuropathy. A visual analog pain scale (VAS) specific to the limb testing the experimental device will be administered prior to, and after, the clinical measures. The VAS scale is measured by the subject's own perspective by using a 0 to 10 scale, with zero indicating no pain and ten being intolerable pain. These baseline metrics will be compared with performance metrics obtained using the same tests delivered at the end of the daily-use period.
Measured: 8 Weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Apr 2022
- Study start28 Apr 2022
- Primary completion10 Apr 2026
- Study completion10 Apr 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Upper Extremity InjuryStudies of the same condition, open and under way.
- More trials run by Mayo ClinicThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Model description
- Crossover design with first intervention randomized.
- Masking
- None (open label)
- Enrolment
- 36 participants (actual)
Sponsor and investigators
- Lead sponsor
- Mayo Clinic
- Sponsor type
- University, hospital or other
- Collaborators
- Arizona State University, Hanger Clinic: Prosthetics & Orthotics
- Responsible party
- Principal investigator, Kristin Zhao, PhD, Mayo Clinic
- Investigators
- Marco Santello, Ph.D., Principal investigator, Arizona State UniversityKristin D. Zhao, Ph.D., Principal investigator, Mayo Clinic
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05328934
- Sponsor's protocol ID
- 21-005070
- Status last verified
- Jun 2026
- First submitted
- 7 Apr 2022
- Last updated
- 12 Jun 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- Yes
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 12 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Toward Use of the Synergy-based SoftHand Pro for Activities of Daily Living by Persons With Transradial Limb Loss: A Multi-site Clinical Trial
- ClinicalTrials.gov ID
- NCT05328934
- Acronym / sponsor ID
- 21-005070
- Conditions
- Upper Extremity Injury, Upper Extremity Deformities, Congenital, Amputation, Traumatic, Amputation, Congenital
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 36 participants (actual)
- Lead sponsor
- Mayo ClinicUniversity, hospital or other
- Collaborators
- Arizona State University, Hanger Clinic: Prosthetics & Orthotics
- Study start
- 28 Apr 2022 (actual)
- Primary completion
- 10 Apr 2026 (actual)
- Study completion
- 10 Apr 2026 (actual)
- First posted
- 14 Apr 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
A trial to compare the performance of the SoftHand Pro (SHP) and Ossur i-Limb in people with transradial limb loss over an 8-week period.
Detailed description
This study will measure improvements in outcomes obtained from laboratory testing of the SHP and i-Limb from baseline to after 8 weeks of daily use. A secondary analysis will incorporate the subjects' existing prosthetic hands. Finally, surveys and usage data collected through the SHP and i-Limb firmware during daily use will complement data the aforementioned outcomes to explore factors that may be related to differences in grasping and manipulation performance.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Crossover design with first intervention randomized.
| Arm | Type | Receives |
|---|---|---|
| Initial Assignment: SoftHand Pro | Experimental | Device: SoftHand Pro, Device: Ossur i-LimbThis arm of the crossover design will begin the trial using the SoftHand Pro. |
| Initial Assignment: Ossur i-Limb | Active comparator | Device: SoftHand Pro, Device: Ossur i-LimbThis arm of the crossover design will begin the trial using the i-Limb. |
Who may qualify
- Ages
- 18 to 99 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- the individual can successfully use their prosthesis, list the components used and that their current prosthesis is fitting properly (by performing a tension analysis);
- the individual had unilateral transradial limb loss more than 6 months before the clinical evaluation because, to use a myoelectric prosthesis, the residual limb volume needs to be stable;
- the individual is a proficient owner of one or more common myoelectric prosthetic hands, such as the Sensor Hand Speed and Bebionic.
Key exclusion criteria (10 listed)
- individuals who have had transradial amputation for less than 6 months;
- individuals who have been fit and trained to use a prosthesis but chose not to use one;
- individuals who use the i-Limb Quantum myoelectric prosthesis;
- symptomatic brachial plexopathy, cervical radiculopathy or polyneuropathy (observed);
- orthopedic, joint degeneration (i.e., arthritis, self-reported) affecting the hand or cervical spine that severely limit upper limb function (observed);
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| SoftHand ProPerformance assessments utilizing the SoftHand Pro over an 8-week period. | Device | Initial Assignment: Ossur i-Limb, Initial Assignment: SoftHand Pro |
| Ossur i-LimbPerformance assessments utilizing the i-Limb over an 8-week period. | Device | Initial Assignment: Ossur i-Limb, Initial Assignment: SoftHand Pro |
Primary outcome
Upper Extremity Functional Ability [1]
Time frame: 8 Weeks
Change in upper extremity function, as measured by the Activities Measure for Upper Limb Amputees (AM-ULA). Participants complete 17 tasks, rated on task completion, speed of completion, movement quality, skillfulness of prosthesis use, and independence from the use of other assistive devices or adaptive environments with the prosthesis. The scale is 0 to 4, with a higher number representing higher performance in each category. Scores in each category are averaged for a Grade in each task. Grades for the 17 tasks are averaged and multiplied by 40 for a final score of 0 - 40, with a higher number representing higher overall function.
9 secondary outcomes
Upper Extremity Functional Ability [2]
Time frame: 8 Weeks
Upper Extremity Manual Dexterity
Time frame: 8 Weeks
Hand Motor Function
Time frame: 8 Weeks
Occupational Performance
Time frame: 8 Weeks
Quality of Life
Time frame: 8 Weeks
Upper Extremity Function and Pain
Time frame: 8 Weeks
Overall Functional Performance
Time frame: 8 Weeks
Prosthesis Overall Functional Utility
Time frame: 8 Weeks
Arm Pain
Time frame: 8 Weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 Jun 2026.
- Individual participant dataSharing planned: No
Related trials for Upper Extremity Injury
Active, not recruitingObservational study
Nerve Transfer Surgery to Restore Upper-limb Function After Cervical Spinal Cord Injury
Spinal Cord Injury, Spinal Cord Injury at C5-C7 Level
Not yet recruiting
Transcutaneous Auricular Vagus Nerve Stimulation to Improve Upper Extremity Recovery After Traumatic Brain Injury
Traumatic Brain Injury, Upper Extremity
RecruitingPhase 4
Study Comparing Avance Nerve Graft and Autograft for Functional Recovery Following Mixed and Motor Peripheral Nerve Reconstruction
Peripheral Nerve Injury, Peripheral Nerve Discontinuity
Not yet recruiting
PhiCube for Bilateral Upper Limb Neuromotor and Cognitive Rehabilitation in Adults
Stroke, Parkinson Disease
Recruiting
ZEPU-2000 Limb Rehabilitation Trainer Study (ZEPU2000RCT)
Stroke, Incomplete Spinal Cord Injury (SCI)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Marco Santello, Ph.D. principal investigator
Arizona State University
Kristin D. Zhao, Ph.D. principal investigator
Mayo Clinic
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing SoftHand Pro and Ossur i-Limb in people with Upper Extremity Injury and Upper Extremity Deformities, Congenital, run by Mayo Clinic at 2 sites in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 12 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Upper Extremity Functional Ability [1] (time frame: 8 Weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jun 2026; AzTrials last refreshed its copy on 26 Oct 2026.